The Faculty of Medicine of Chulalongkorn University is expected to begin the first phase of candidate COVID-19 vaccine trials in humans next April. Should the vaccine candidate pass phase 1 and 2 trials, and the efficacy and safety assessments, the large scale production could begin in late 2021.